Friday, January 18, 2013

• Alnylam Investors: Hit With Dilutionat Motley Fool (Fri, Jan 18)

Wednesday, January 16, 2013

• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 16)
• Alnylam Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common StockBusiness Wire (Wed, Jan 16)
• Alnylam Prices Public OfferingZacks (Wed, Jan 16)
• Alnylam looking to raise $125 million in stock offeringat bizjournals.com (Wed, Jan 16)

Tuesday, January 15, 2013

• Alnylam Pharmaceuticals Prices Public Offering of Common StockBusiness Wire (Tue, Jan 15)
• Alnylam to Raise $125 MillionZacks (Tue, Jan 15)

Monday, January 14, 2013

• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 14)
• Alnylam Pharmaceuticals Announces Proposed Public Offering of $125 Million of Common StockBusiness Wire (Mon, Jan 14)

Wednesday, January 9, 2013

• Alnylam's CEO Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript)at Seeking Alpha (Wed, Jan 9)

Tuesday, January 8, 2013

• Pipeline Update from AlnylamZacks (Tue, Jan 8)

Monday, January 7, 2013

• IPO-bound Zafgen names former Alnylam finance exec as CFOat bizjournals.com (Mon, Jan 7)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online (Mon, Jan 7)

Sunday, January 6, 2013

• Alnylam Provides Key 2013 – 2014 Goals for RNAi Therapeutics PipelineBusiness Wire (Sun, Jan 6)

Thursday, January 3, 2013

• Alnylam Files Clinical Trial Application to Initiate a Phase I Study for ALN-TTRsc, a Subcutaneously Administered RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR)Business Wire (Thu, Jan 3)

Wednesday, January 2, 2013

• Alnylam to Webcast Presentation at 31st Annual J.P. Morgan Healthcare ConferenceBusiness Wire (Wed, Jan 2)
• Biotechs dominate list of top-performing Boston-area stocks in 2012at bizjournals.com (Wed, Jan 2)

Wednesday, December 19, 2012

• When Compared To Isis, Alnylam's Valuation Does Not Make Senseat Seeking Alpha (Wed, Dec 19)

Tuesday, December 18, 2012

• Alnylam Falls Behind The Competitionat Seeking Alpha (Tue, Dec 18)

Thursday, December 13, 2012

• 2 Biotech Stocks To Consider This Week In The Wake Of Trial Dataat Seeking Alpha (Thu, Dec 13)

Wednesday, December 12, 2012

• Alnylam shares rise following analyst upgradeAP (Wed, Dec 12)
• Eli Lilly and Other Healthcare Stocks Making Big Moves on December 12, 2012at Investopedia (Wed, Dec 12)

Monday, December 10, 2012

• Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemophilia and Other Bleeding Disorders at 54th American Society of Hematology (ASH) Annual MeetingBusiness Wire (Mon, Dec 10)

Sunday, December 9, 2012

• Alnylam presents new pre-clinical data on RNAi therapeuticstheflyonthewall.com (Sun, Dec 9)

Saturday, December 8, 2012

• Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemoglobinopathies at 54th American Society of Hematology (ASH) Annual MeetingBusiness Wire (Sat, Dec 8)

Add ALNY News to My Yahoo!